Skip to main content
. 2015 Jun 17;10(6):e0123683. doi: 10.1371/journal.pone.0123683

Fig 6. Kaplan-Meier estimate of Progression-Free-Survival (PFS) in patients with metaststic breast cancer receiving lapatinib (n = 21).

Fig 6